Riskpilot← Back to searchSign inGet full accessFrostPharma AB
ABActiveOrg 5568141708Berga Backe 2Activities of agents involved in the wholesale of other particular products · NACE 4618Est. 201020-49 employees
Revenue 2024
SEK 275,1M
+50% vs 2023
EBITDA margin
17.3%
+161% vs 2023
Equity ratio
50.1%
Financial strength
Net profit 2024
SEK 21,5M
+164% vs 2023
| Revenue | SEK 275,1M | +50% |
| EBITDA | SEK 47,7M | +161% |
| Net profit | SEK 21,5M | +164% |
| Total assets | SEK 388,2M | +205% |
| Equity | SEK 194,4M | +457% |
| Employees | — | — |
Legal name
FrostPharma AB
Org number
5568141708
Legal form
Aktiebolag
NACE code
4618 · Activities of agents involved in the wholesale of other particular products
Founded
7 juli 2010
Share capital
SEK 60 000
Employees
20-49
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas av en av Nilsson, Lena Louise Willén, Erik Karl-Johan i förening med en av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Aktiebolagets verksamhet ska vara att bedriva försäljning, marknadsföring, agentur samt distribution av läkemedel och medicintekniska produkter jämte därmed förenlig verksamhet.
Address
Berga Backe 2
Phone
+468243660
Email
info@frostpharma.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 20 081 | 51 760 | 163 201 | 79 206 | 139 364 | 183 010 | 275 070 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −3 987 | −1 091 | 32 | 224 | 1 716 | 3 416 | −3 642 | 31 106 | 18 301 | 47 679 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −14 | −664 | −1 460 | −5 518 |
| EBIT | −3 987 | −1 091 | 32 | 224 | 1 716 | 3 416 | −3 656 | 30 442 | 16 841 | 42 161 |
| Net financials | −74 | −652 | −2 | −188 | −677 | −2 258 | −1 914 | −2 132 | −2 836 | −5 926 |
| Profit before tax | 120 | −1 742 | 30 | 36 | 950 | 1 157 | −5 480 | 22 536 | 10 455 | 27 334 |
| Tax | −50 | −0 | −0 | −0 | −58 | −294 | −0 | −3 590 | −2 314 | −5 804 |
| Net profit | 70 | −1 742 | 30 | 36 | 892 | 863 | −5 480 | 18 946 | 8 141 | 21 530 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3 658 | 994 | 2 511 | 11 249 | 41 991 | 60 130 | 60 925 | 100 238 | 127 197 | 388 185 |
| Equity | 2 428 | 288 | 319 | 355 | 1 247 | 2 110 | 6 630 | 26 740 | 34 881 | 194 411 |
| Long-term debt | 0 | 0 | 0 | 5 206 | 17 590 | 34 926 | 0 | 0 | 39 262 | 99 009 |
| Short-term debt | 1 230 | 706 | 2 192 | 5 688 | 23 065 | 23 004 | 54 295 | 67 724 | 43 730 | 76 541 |
| Total debt | 1 230 | 706 | 2 192 | 10 894 | 40 655 | 57 930 | 54 295 | 67 724 | 82 992 | 175 550 |
EBITDA margin
17.3%
This company
15.8%
Market median
+9% vs market
20152024
Equity ratio
50.1%
This company
38.2%
Market median
+31% vs market
20152024
Return on equity
11.1%
This company
18.4%
Market median
+40% vs market
20152024
Net profit margin
7.8%
This company
8.1%
Market median
-4% vs market
20152024
Asset turnover
0.71×
This company
1.12×
Market median
-37% vs market
20152024
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LM Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
AM Audit | Audit | 2020 | — | — |
CF Chief Executive Officer | Chief Executive Officer | 2026 | — | — |
KK Chief Auditor | Chief Auditor | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2020 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2023 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
FrostPharma Holding AB | Company | 100.0% | 100.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Priveq Holding VI AB
FrostPharma AB Board members of FrostPharma AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Magnus Nylén | Chief Executive Officer | 0 companies |
| Anna Maria Andersson | Audit | 0 companies |
| Carl Fredrik Oskar S Andersch | Chief Executive Officer | 0 companies |
| Kajsa Karin Helena Goding | Chief Auditor | 0 companies |
| Ebba Cecilia Bröms | Deputy Board Member | 0 companies |
| Roger Carl-Gunnar Tapper | Board of Directors | 0 companies |
| Clas Fredrik Lindbergson | Board of Directors | 0 companies |
| Eva Charlotta Walde | Board of Directors | 0 companies |
| Daniel Mats Filip Nylund | Deputy Board Member | 0 companies |
| Rolf Allan Classon | Chairman | 0 companies |
| Erik Karl-Johan Willén | Board of Directors | 0 companies |
| Sven Christer Ahlberg | Board of Directors | 0 companies |
| Lena Louise Nilsson | Board of Directors | 0 companies |